The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-κB and caspase activation

British Journal of Pharmacology

Volumn 155, Issue 6, 2008, Pages 945-956

  Campo, G M ^a   Avenoso, A ^a   Campo, S ^a   Nastasi, G ^a   Traina, P ^a   D'Ascola, A ^a   Rugolo, C A ^a   Calatroni, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Antioxidants; Carbon tetrachloride; Caspases; Chondroitin 4 sulphate; Free radicals; Liver damage; NF B; Oxidative stress

Indexed keywords

CARBON TETRACHLORIDE; CASPASE 3; CASPASE 7; CHONDROITIN 4 SULFATE; GLUTATHIONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HISTOLOGY; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; CASPASES; CHONDROITIN SULFATES; ENZYME ACTIVATION; HEPATITIS, TOXIC; MALE; MICE; MICE, INBRED STRAINS; NF-KAPPA B; RANDOM ALLOCATION;

EID: 57349145788     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.338     Document Type: Article

References (38)

1. Arai H, Kashiwagi S, Nagasaka Y, Uchida K, Hoshii Y, Nakamura K (1999). Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. Arch Biochem Biophys 367: 1-8.
2. Bhattacharyya J, Biswas S, Datta AG (2004). Mode of action of endotoxin: role of free radicals and antioxidants. Curr Med Chem 11: 359-368.
3. Blair PC, Thompson MB, Wilson RE, Esber HH, Maronpot RR (1991). Correlation of changes in serum analytes and hepatic histopathology in rats exposed to carbon tetrachloride. Toxicol Lett 55: 149-159.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Bustin SA (2000). Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
6. Campo GM, Avenoso A, Campo S, D'Ascola A, Ferlazzo AM, Calatroni A (2004a). The antioxidant and antifibrogenic effect of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis. Chem Biol Interact 148: 125-138.
7. Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Samà D et al. (2008). NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate exerted antioxidant effect in fibroblast cultures exposed to oxidative stress. J Appl Toxicol 28: 309-317.
8. Campo GM, Avenoso A, Campo S, Ferlazzo AM, Calatroni A (2006). Chondroitin sulphate: antioxidant properties and beneficial effects. Mini Rev Med Chem 6: 1311-1320.
9. Campo GM, Avenoso A, Campo S, Ferlazzo AM, Micali C, Zangh L et al. (2004b). Hyaluronic acid and chondroitin-4-sulphate treatment reduces damage in carbon tetrachloride-induced acute rat liver injury. Life Sciences 74: 1289-1305.
10. Campo GM, D'Ascola A, Avenoso A, Campo S, Ferlazzo AM, Micali C et al. (2004c). Glycosaminoglycans reduce oxidative damage induced by copper (Cu+2), iron (Fe+2) and hydrogen peroxide (H2O2) in human fibroblast cultures. Glycoconj J 20: 133-141.
11. Cartel NJ, Post M (2005). Abrogation of apoptosis through PDGF-BB-induced sulphated glycosaminoglycans synthesis and secretion. Am J Physiol Lung Cell Mol Physiol 288: L285-L293.
12. Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008). The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40: 1362-1378.
13. Ding WX, Yin XM (2004). Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury. J Cell Mol Med 8: 445-454.
14. Genestra M (2007). Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19: 1807-1819.
15. Ham YM, Lim JH, Na HK, Choi JS, Park BD, Yim H et al. (2006). Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with ROS-and Ca2+-mediated JNK1 activation in HeLa cells. J Pharmacol Exp Ther 319: 1276-1285.
16. Heyninck K, Wullaert A, Beyaert R (2003). Nuclear factor-kappa B plays a central role in tumor necrosis factor-mediated liver disease. Biochem Pharmacol 66: 1409-1415.
17. Kundu JK, Shin YK, Surh YJ (2006). Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol 72: 1506-1515.
18. Lee KS, Cottam HB, Houglum K, Wasson DB, Carson D, Chojkier M (1997). Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol 273: G1094-G1100.
19. Maksimenko AV (2005). Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase. Curr Pharm Des 11: 2007-2016.
20. Malhi H, Gores GJ, Lemasters JJ (2006). Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43: S31-S44.
21. Nelson KK, Melendez JA (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37: 768-784.
22. Oral B, Guney M, Demirin H, Ozguner M, Giray SG, Take G et al. (2006). Endometrial damage and apoptosis in rats induced by dichlorvos and ameliorating effect of antioxidant Vitamins E and C. Reprod Toxicol 22: 783-790.
23. Orfila C, Lepert JC, Alric L, Carrera G, Beraud M, Pipy B (2005). Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferators-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol 123: 585-593.
24. Ozben T (2007). Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96: 2181-2196.
25. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM (2006). Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8: 1791-1806.
26. Pineiro-Carrero VM, Pineiro EO (2004). Liver. Pediatrics 113: 1097-1106.
27. Poli G (2000). Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21: 49-98.
28. Rolls A, Cahalon L, Bakalash S, Avidan H, Lider O, Schwartz M (2006). Asulphated disaccharide derived from chondroitin sulphate proteoglycan protects against inflammation-associated neurodegeneration. FASEB J 20: 547-549.
29. Sawant SP, Dnyanmote AV, Shankar K, Limaye PB, Latendresse JR, Mehendale HM (2004). Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J Pharmacol Exp Ther 308: 694-704.
30. Schattenberg JM, Galle PR, Schuchmann M (2006). Apoptosis in liver disease. Liver Int 26: 904-911.
31. Stehbens WE (2003). Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol 75: 265-276.
32. Sun AY, Ingelman-Sunberg M, Neve E, Matsumoto H, Nishitani Y, Minowa Y et al. (2001). Ethanol and oxidative stress. Alcohol Clin Exp Res 25 (5 Suppl ISBRA): 237S-243S.
33. Volpi N (2006). Chondroitin sulfate: structure, role and pharmacological activity. Adv Pharmacol Elsevier 53.
34. Wang T, Shankar K, Ronis MJ, Mehendale HM (2007). Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit Rev Toxicol 37: 413-459.
35. Waris G, Tardif KD, Siddiqui A (2002). Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol 64: 1425-1430.
36. Weber LW, Boll M, Stampfl A (2003). Hepatotoxicity and mechanism of action of haloakanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33: 105-136.
37. Weiler-Normann C, Herkel J, Lohse AW (2007). Mouse models of liver fibrosis. Z Gastroenterol 45: 43-50.
38. Wu D, Zhai Q, Shi X (2006). Alcohol-induced oxidative stress and cell responses. J Gastroenterol Hepatol 21 (Suppl.3): S26-S29.